Sign up to save your podcasts
Or
Share INVOS™ technology overview pt 7: How is the algorithm developed for the pediatric population?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
INVOS™ technology overview pt 7: How is the algorithm developed for the pediatric population?
Eli Kuhlmann, Sr. Research Manager at Medtronic, describes how the INVOS™ system pediatric algorithm was developed in order to account for factors impacting regional oximetry measurements in pediatric patients. The INVOS™ monitoring system should not be used as the sole basis for diagnosis or therapy and is intended only as an adjunct in patient assessment.
View all episodes
By MedtronicEli Kuhlmann, Sr. Research Manager at Medtronic, describes how the INVOS™ system pediatric algorithm was developed in order to account for factors impacting regional oximetry measurements in pediatric patients. The INVOS™ monitoring system should not be used as the sole basis for diagnosis or therapy and is intended only as an adjunct in patient assessment.